US BROKER MOVES: MA upgraded at BNPP; MU downgraded at Summit Insights

UPGRADES Carnival (CCL) Upgraded from Equalweight to Overweight W/ USD 31.00 PT (prev. USD 33.00) at Morgan Stanley Cross Country Healthcare (CCRN) Upgraded from Neutral to Outperform W/ USD 15.00 PT (prev. USD 11.00) at Wedbush Five Below (FIVE) Upgraded from Market Perform to Outperform at William Blair Fluence Energy (FLNC) Upgraded from Sell to Neutral at Guggenheim Kohl’s (KSS) Upgraded from Reduce to Buy W/ USD 20.00 PT at Gordon Haskett Mastercard (MA) Upgraded from Neutral to Outperform W/ USD 600.00 PT at BNP Paribas Exane MoonLake Immunotherapeutics (MLTX) Upgraded from Neutral to Buy W/ USD 40.00 PT (prev. USD 12.00) at Rothschild Redburn Nu Holdings (NU) Upgraded from Neutral to Buy W/ USD 17.60 PT (prev. USD 17.20) at UBS SouthState Corporation (SSB) Upgraded from Market Perform to Outperform at Hovde Group Union Pacific (UNP) Upgraded from In Line to Outperform W/ USD 262.00 PT (prev. USD 260.00) at Evercore ISI DOWNGRADES CSX (CSX) Downgraded from Outperform to In Line W/ USD 41.00 PT (prev. USD 40.00) at Evercore ISI Freshworks (FRSH) Downgraded from Outperform to Perform at Oppenheimer Kinsale Capital Group (KNSL) Downgraded from Hold to Underperform W/ USD 312.00 PT (prev. USD 392.00) at Jefferies Micron Technology (MU) Downgraded from Buy to Hold at Summit Insights Xponential Fitness (XPOF) Downgraded from Strong Buy to Market Perform at Raymond James INITIATIONS  Aligos Therapeutics (ALGS) Initiated Buy W/ USD 48.00 PT at Jefferies ALX Oncology (ALXO) Initiated Overweight W/ USD 5.00 PT at Wells Fargo EnerSys (ENS) Initiated Buy W/ USD 190.00 PT at TD Cowen Okta (OKTA) Initiated Outperform W/ USD 100.00 PT at Macquarie Olema Pharmaceuticals (OLMA) Initiated Buy W/ USD 40.00 PT at Jefferies Companhia de Saneamento Básico do Estado de São Paulo (SBS) Initiated Buy W/ USD 36.60 PT at Jefferies Vor Biopharma (VOR) Initiated Overweight W/ USD 30.00 PT at Wells Fargo